Valuation: SSY Group Limited

Market Cap 7.65B 976M 836M 783M 716M 1.35B 93.02B 1.36B 9.24B 3.6B 46.93B 3.66B 3.58B 155B P/E 2026 *
12.9x
P/E 2027 * 10.5x
Enterprise Value 7.65B 976M 836M 783M 716M 1.35B 93.02B 1.36B 9.24B 3.6B 46.93B 3.66B 3.58B 155B EV / Sales 2026 *
1.57x
EV / Sales 2027 * 1.4x
Free-Float
33.48%
Yield 2026 *
3.98%
Yield 2027 * 4.37%
1 day+5.17%
1 week+9.52%
Current month+11.13%
1 month+10.21%
3 months+11.60%
6 months-5.87%
Current year-6.54%
1 week 2.43
Extreme 2.43
2.66
1 month 2.36
Extreme 2.36
2.66
Current year 2.01
Extreme 2.01
3.15
1 year 2.01
Extreme 2.01
3.4
3 years 2.01
Extreme 2.01
5.2
5 years 2.01
Extreme 2.01
5.68
10 years 2.01
Extreme 2.01
9.46
Manager TitleAgeSince
Chief Executive Officer 69 23/03/2010
Director of Finance/CFO 45 01/04/2015
Corporate Officer/Principal 42 28/08/2024
Director TitleAgeSince
Chairman 69 04/06/2014
Director/Board Member 61 26/07/2007
Director/Board Member 57 16/10/2005
Date Insider Type Main position Quantity % Market Cap.
09/01/26 Other

Chief Executive Officer

456,000 0.0155%
08/01/26 Other

Chief Executive Officer

1,486,000 0.0504%
07/01/26 Other

Chief Executive Officer

1,128,000 0.0382%
Change 5-day change 1-year change 3-year change Capi.($)
+5.17%+9.52%-14.68%-34.37% 928M
-2.63%-5.52%+64.35%+118.38% 1,100B
-0.96%-1.10%+53.21%+64.59% 658B
-1.85%-1.51%+25.72%+77.67% 470B
-1.44%+0.33%+42.21%+42.23% 372B
-0.75%+0.20%+25.77%+40.81% 304B
-1.79%+1.58%+3.10%+13.29% 264B
-0.58%-0.45%+52.07%+71.64% 239B
-0.93%+1.84%-13.11%-52.83% 213B
-0.15%+0.79%+29.64%+93.09% 184B
Average -0.59%+3.12%+26.83%+43.45% 380.38B
Weighted average by Cap. -1.58%+2.21%+41.36%+69.36%

Financials

2026 *2027 *
Net sales 4.88B 622M 533M 500M 456M 861M 59.32B 870M 5.89B 2.29B 29.93B 2.34B 2.29B 99.11B 5.47B 698M 598M 561M 512M 966M 66.56B 976M 6.61B 2.57B 33.58B 2.62B 2.56B 111B
Net income 587M 74.9M 64.18M 60.14M 54.93M 104M 7.14B 105M 709M 276M 3.6B 281M 275M 11.93B 702M 89.5M 76.69M 71.86M 65.64M 124M 8.53B 125M 848M 330M 4.3B 336M 329M 14.26B
Net Debt - -
Logo SSY Group Limited
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Employees
5,472
Date Price Change Volume
26/08/26 HK$2.645 +5.17% 15,194,000
25/08/26 HK$2.515 +2.03% 6,182,000
24/08/26 HK$2.465 -0.40% 6,210,000
21/08/26 HK$2.475 +1.23% 2,578,000
20/08/26 HK$2.445 +1.87% 10,526,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.515HKD
Average target price
3.640HKD
Spread / Average Target
+44.73%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2005 Stock